SIRT2 and breast cancer: However, the Kaplan–Meier plot indicates no significantly different overall survival of BC patients in the altered and unaltered SIRT2 groups despite the fact that, according to the cBio database, the median survival overall was 100.70 months for the altered group and 152.07 months for the unaltered group (95% CI) (Figure 2D).